Capability
Private Capital
Advisory around private-market capital options across different stages of company development.
Overview
Private markets have broadened considerably. Growth equity, later-stage venture, private credit, hybrid instruments and secondary liquidity now sit alongside one another, and the right answer depends on the company's stage, economics and objectives.
A wider set of options
Technology companies are no longer choosing between a priced equity round and nothing. Structured instruments, minority growth investments and non-dilutive alternatives all have a place, and each carries different implications for control and downside.
Stage and suitability
Capital that is well suited to a company at one stage can constrain it at the next. We work with management teams to consider suitability across the whole trajectory rather than the immediate requirement alone.
Cost of capital in practice
Cost of capital is rarely a single number. Dilution, coupon, security, covenants, consent rights and exit mechanics combine into an effective cost that only becomes visible when the terms are read together.
Shareholder considerations
Existing shareholders, founders and employee equity holders are all affected by the structure of a private capital transaction. Anticipating those consequences early avoids difficult conversations at signing.
Sequencing
The order in which a company raises, and from whom, shapes the options available afterwards. Sequencing is a strategic decision, not an administrative one.
Private-market instruments
The questions that shape the outcome.
- Minority growth equity
- Later-stage venture capital
- Structured and hybrid instruments
- Private credit and non-dilutive alternatives
- Secondary liquidity for founders and early shareholders
Working with Wrotham
Senior attention, throughout.
Engagements begin with a conversation about objectives rather than instruments. Understanding what the business is trying to achieve, and over what horizon, determines everything that follows.
We take a limited number of mandates so that each receives senior attention from beginning to end, and we are direct about timing, positioning and expectations from the outset.
Related
Other capabilities.
- Equity CapitalSupport for technology companies considering institutional equity capital for growth, expansion and strategic development.
- Investor AccessConnecting relevant companies and capital providers where strategic and investment objectives align.
- Capital StrategyHelping management teams think through capital requirements, positioning and the broader financing landscape.
- Strategic CapitalCapital relationships that may provide strategic as well as financial value.
Discuss your capital strategy.
A confidential conversation about objectives, timing and the options available.